DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Iodophenyl is an investigational drug.
There have been 9 clinical trials for Iodophenyl. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2009.
The most common disease conditions in clinical trials are Parkinson Disease, Behavior, Addictive, and Acute Coronary Syndrome. The leading clinical trial sponsors are Cellectar Biosciences, Inc., Section of Biostatistics University of Copenhagen, Copenhagen, and Pfizer.
Recent Clinical Trials for Iodophenyl
|Trametinib and TAS-102 in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery||City of Hope Medical Center||Phase 1|
|Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?||Neurobiology Research Unit, Rigshospitalet, Copenhagen||Phase 2|
|Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?||Section of Biostatistics University of Copenhagen, Copenhagen||Phase 2|